Dicerna Pharmaceuticals, Inc. (NASDAQ:DRNA), a leader in the development of RNAi-based therapeutics, today announced that Douglas M. Fambrough, PhD, President and CEO, will present at three upcoming conferences, including the 2014 Leerink Rare Disease Roundtable, Bernstein’s Genes as Drugs Event, and the 13th Annual BIO Investor Forum. In addition to the corporate update presentation at Bernstein’s event, Dr. Fambrough will participate in a panel with other industry leaders.
Help employers find you! Check out all the jobs and post your resume.
Help employers find you! Check out all the jobs and post your resume.
